Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Erratum

Erratum to ‘Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023’ [Clin Mol Hepatol 2025;31:e235-e238]

Donghee Kim, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(4):1387-1388. Published online October 1, 2025

DOI: https://doi.org/10.3350/cmh.2024.1150e
Corrects: Clin Mol Hepatol 2025;31(3):e235

View: 443 Download: 4

Letter to the Editor

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023

Donghee Kim, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(3):e235-e238. Published online December 30, 2024

DOI: https://doi.org/10.3350/cmh.2024.1150 Correction in: Clin Mol Hepatol 2025;31(4):1387

View: 7152 Download: 220 Web of Science: 1 Crossref: 5

Correspondence

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(2):e183-e185. Published online February 17, 2025

DOI: https://doi.org/10.3350/cmh.2025.0152

View: 3591 Download: 16 Web of Science: 1 Crossref: 3

Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(2):e180-e182. Published online February 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0125

View: 3866 Download: 24

Original Article

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021

Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab

Clin Mol Hepatol. 2025;31(2):525-547. Published online January 9, 2025

DOI: https://doi.org/10.3350/cmh.2024.0835

View: 10676 Download: 370 Web of Science: 18 Crossref: 23

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(2):382-393. Published online November 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0987

View: 9719 Download: 513 Web of Science: 20 Crossref: 30

Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis

Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang

Clin Mol Hepatol. 2022;28(4):864-875. Published online July 25, 2022

DOI: https://doi.org/10.3350/cmh.2022.0136

View: 10462 Download: 180 Web of Science: 29 Crossref: 31

Review

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray

Clin Mol Hepatol. 2020;26(4):383-400. Published online July 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0067

View: 15824 Download: 553 Web of Science: 66 Crossref: 67

Review Article

Incretin-based therapies for Cardio-Kidney-Liver-Metabolic (CKLM) Disease: The role of the liver in the modern era of chronic disease management.

Harendran Elangovan, Rohit Loomba, Mark Muthiah, Jörn Schattenberg, Ming Hua Zheng, Mazen Noureddin, Christos Mantzoros, Jacob George

Received August 1, 2025 Accepted October 26, 2025

DOI: https://doi.org/10.3350/cmh.2025.0857 [Accepted]

View: 246 Download: 30

1 |

Viewed By 19589	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 15492	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 10949	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 10944	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 9088	MAFLD: How is it different from NAFLD?

Cited By 434	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 420	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 278	MAFLD: How is it different from NAFLD?
Cited By 206	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Cited By 148	Non-alcoholic fatty liver disease: Definition and subtypes

Search